Chris Markoch

Chris Markoch

InvestorPlace Contributor

Chris Markoch is a freelance financial writer who brings over 25 years in sales and marketing to help find the story behind the stock. Chris starts by asking the question, “So what?” and then uses fundamental and (some) technical analysis to add depth to that insight.

Stepping back from the “what” allows Chris to bring perspective that helps investors make wise decisions based on their risk tolerance and investing timeline.

Markoch would describe his writing as being for investors more than traders. He looks at equities through a long-term lens and that is reflected in his writing.

In addition to his articles on InvestorPlace, you can also find Chris’ writing on MarketBeat.com where he has collaborated on the e-book “5 Investing Trends That Will Define the Market in 2022.” You can find Chris on LinkedIn and on Twitter.

Recent Articles

There’s a Tangible Reason to Consider Buying Ethereum

By Chris Markoch, InvestorPlace Contributor

Ethereum is a logical candidate for decentralized finance applications. And that gives the coin an ability to capture more of the crypto market.

Investors Go Looking for a ‘Why’ To Justify Buying Ideanomics Stock

By Chris Markoch, InvestorPlace Contributor

Ideanomics is linked to the EV sector which seems to be a sufficient reason for investors to buy IDEX stock. But should it be?

Every Dog Has Its Day, but Dogecoin’s May Have Already Passed

By Chris Markoch, InvestorPlace Contributor

Dogecoin is having its fifteen minutes of fame. How long that will last is anyone's guess, but before you buy, make sure you separate fact from feelings.

9 Epicenter Stocks That Are Rebounding After a Hard Pandemic Fall

By Chris Markoch, InvestorPlace Contributor

What goes down, must come up, right? That's the argument for buying these epicenter stocks that saw their businesses affected by the pandemic.

Stellar Lumens Still Has One of the Best Stories to Ride the Crypto Wave

By Chris Markoch, InvestorPlace Contributor

XLM has a high correlation with Bitcoin. But there's more to this crypto's story. And that's why the rally in Stellar Lumens may not be over.

Organigram Is Coming Back to Earth, And That’s Good for Speculative Investors

By Chris Markoch, InvestorPlace Contributor

OGI stock is nearing its 2020 levels. However, at $3 the stock is a more realistic bet than when it was trading at $6.

Let’s All Take a Breath on the Foley Trasimene Acquisition SPAC

By Chris Markoch, InvestorPlace Contributor

Before you buy BFT stock, it's important for you understand Paysafe's underdog role in the online payment processing universe.

Carnival Is Climbing Too High Too Fast

By Chris Markoch, InvestorPlace Contributor

CCL stock has climbed within hailing distance of its pre-pandemic price. But it's hard to justify a 2019 price with normal revenue not coming until 2022.

7 Robinhood Stocks To Buy for Your Penny Stocks Portfolio

By Chris Markoch, InvestorPlace Contributor

Robinhood has attracted a new group of traders to penny stocks. And with a little bit of homework, these seven penny stocks could have real upside.

Workhorse Group Is Looking for a Plan B

By Chris Markoch, InvestorPlace Contributor

WKHS stock still has a value after losing what would have been a breakthrough contract, albeit much lower than before.

Load More